Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Contineum Therapeutics

Clinical trials sponsored by Contineum Therapeutics, explained in plain language.

Trials to join now! 1 Completed 2

New oral drug trial aims to slow scarring in fatal lung disease

Disease control Recruiting now

This study is testing whether an oral medication called PIPE-791 can slow the progression of idiopathic pulmonary fibrosis (IPF), a serious disease that causes permanent lung scarring. About 324 adults with IPF will take either PIPE-791 or a placebo pill for 26 weeks to see if th…

Phase: PHASE2 • Sponsor: Contineum Therapeutics • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC